S. La Rosa et al., Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry, VIRCHOWS AR, 437(3), 2000, pp. 264-269
Citations number
34
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
Gonadotropin-releasing hormone (GnRH), which is a well-known regulator of g
onadotroph function, has recently been considered to be a paracrine factor
involved in the control of somatotroph, lactotroph, and corticotroph cells.
GnRH action is initiated by binding to a specific cell surface receptor, t
he gonadotropin-releasing hormone receptor (GnRHR), which is expressed by f
ollicle-stimulating hormone/luteinizing hormone (FSH/LH) cells. Using in si
tu hybridization techniques, GnRHR messenger ribonucleic acid (mRNA) has re
cently been detected in normal human anterior pituitary gland and in variou
s pituitary adenomas, including FSH/LH-cell, growth hormone (GH)-cell, adre
nocorticotropic hormone (ACTH)-cell, and null-cell adenomas. However, immun
ohistochemical studies indicating the specific cell distribution of GnRHR i
n normal pituitary cells have never been reported. The aim of the present i
nvestigation was to evaluate the immunohistochemical expression of GnRHR in
different types of normal pituitary cells and related tumors. Using double
-label immunohistochemical techniques on formalin-fixed and paraffin-embedd
ed tissues and specific antibodies directed against pituitary hormones and
GnRHR, we found GnRHR immunoreactivity not only in FSH/LH cells, but also i
n GH- and thyroid-stimulating hormone (TSH) cells. GnRHR was detected in FS
H/LH-cell, GH-cell, mixed GH- and prolactin (PRL)-cell, and alpha-subunit (
alpha-SU)/null-cell adenomas. The findings of this study suggest that the i
nteraction between GnRH and GnRHR may play a role in paracrine/autocrine re
gulation of different types of normal pituitary cells and pituitary adenoma
s.